Beta Bionics, Inc. Common Stock

BBNXNASDAQ • USD
ThemeMedical Devices & HealthTech›Wearable Medical Devices
18.96 USD
↗ 0.09 (0.48%)AT CLOSE (03:59 PM EDT)
18.95
↘ 0.01 (0.05%)
POST MARKET (AS OF 07:31 PM EDT)
Post Market
AS OF 07:31 PM EDT
18.95
↘ 0.01 (0.05%)
🔴Market: CLOSED

Beta Bionics, Inc. Common Stock (BBNX) trades at $18.96 per share. Technicals currently rate "Neutral" while our fundamental analysis reads "Neutral". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On the valuation front, BBNX trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.

Technical & fundamental data as of Oct 2, 2026.

Open?$18.87
High?$19.26
Low?$18.27
Prev. Close?$18.87
Volume?515.1K
Avg. Volume?1.3M
VWAP?$18.83
Rel. Volume?0.41x
Bid / Ask
Bid?$15.56 × 100
Ask?$21.62 × 100
Spread?$6.06
Midpoint?$18.59
Valuation & Ratios
Market Cap?1.0B
Shares Out?45.0M
Float?28.4M
Float %?63.0%
P/E Ratio?N/A
P/B Ratio?3.99
EPS?-$1.35
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
Themes
Medical Devices & HealthTech›Wearable Medical DevicesDigital Health & Telemedicine›Remote Patient Monitoring
Employees
423
Market Cap
1.0B
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Website
www.betabionics.com
Listed
2025-01-30
Address
11 HUGHES
IRVINE, CA 92618
Phone: 949-427-7785
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
85
Short Sent.?
11
Piotroski F-Score?0/9Weak
Altman Z-Score?15.36Safe
Confidence?45%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?37.44%Squeeze Risk
Short Interest?10.6M
Days to Cover?9.9
Free Float28.4M
Avg Daily Volume1.1M
Settlement Date2026-09-15
Financial Health
Current Ratio?8.88Strong
Quick Ratio?7.96Strong
Cash Ratio?1.70Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
58/100
P/E?
N/A▾
P/B?
Peers
100
S&P
45
3.99FAIR▾
P/S?
Peers
100
S&P
11
8.59HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-12.1CHEAP▾
EV/Sales?
Peers
100
S&P
16
8.22HIGH▾
Returns & Efficiency
ROE?
S&P
6
-28.5%WEAK▾
ROA?
S&P
3
-25.0%WEAK▾
Cash Flow & Enterprise
FCF?$-61411000
Enterprise Value?$978.5M
Fundamentals ratios updated end of day
MarketsMoversWatchlist